These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. Yadav VN; Pyaram K; Mullick J; Sahu A J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095 [TBL] [Abstract][Full Text] [Related]
4. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein. Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894 [TBL] [Abstract][Full Text] [Related]
5. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Rosengard AM; Liu Y; Nie Z; Jimenez R Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8808-13. PubMed ID: 12034872 [TBL] [Abstract][Full Text] [Related]
6. Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity. Kotwal GJ Protein Cell; 2010 Dec; 1(12):1084-92. PubMed ID: 21213103 [TBL] [Abstract][Full Text] [Related]
7. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I. Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763 [TBL] [Abstract][Full Text] [Related]
8. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. Yadav VN; Pyaram K; Ahmad M; Sahu A J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591 [TBL] [Abstract][Full Text] [Related]
9. Glycosylated and nonglycosylated complement control protein of the lister strain of vaccinia virus. Meseda CA; Kuhn J; Atukorale V; Campbell J; Weir JP Clin Vaccine Immunol; 2014 Sep; 21(9):1330-8. PubMed ID: 25030055 [TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. Bernet J; Mullick J; Panse Y; Parab PB; Sahu A J Virol; 2004 Sep; 78(17):9446-57. PubMed ID: 15308738 [TBL] [Abstract][Full Text] [Related]
11. Regulation of complement activity by vaccinia virus complement-control protein. McKenzie R; Kotwal GJ; Moss B; Hammer CH; Frank MM J Infect Dis; 1992 Dec; 166(6):1245-50. PubMed ID: 1431243 [TBL] [Abstract][Full Text] [Related]
12. Identification of complement regulatory domains in vaccinia virus complement control protein. Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165 [TBL] [Abstract][Full Text] [Related]
13. Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics. Zhang L; Morikis D Biophys J; 2006 May; 90(9):3106-19. PubMed ID: 16473914 [TBL] [Abstract][Full Text] [Related]
14. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein. Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343 [TBL] [Abstract][Full Text] [Related]
15. Monkeypox virus and insights into its immunomodulatory proteins. Weaver JR; Isaacs SN Immunol Rev; 2008 Oct; 225():96-113. PubMed ID: 18837778 [TBL] [Abstract][Full Text] [Related]
16. Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment. Liszewski MK; Bertram P; Leung MK; Hauhart R; Zhang L; Atkinson JP J Immunol; 2008 Sep; 181(6):4199-207. PubMed ID: 18768877 [TBL] [Abstract][Full Text] [Related]
17. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity. Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094 [TBL] [Abstract][Full Text] [Related]
18. Elucidating the role of the complement control protein in monkeypox pathogenicity. Hudson PN; Self J; Weiss S; Braden Z; Xiao Y; Girgis NM; Emerson G; Hughes C; Sammons SA; Isaacs SN; Damon IK; Olson VA PLoS One; 2012; 7(4):e35086. PubMed ID: 22496894 [TBL] [Abstract][Full Text] [Related]
19. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. Estep RD; Messaoudi I; O'Connor MA; Li H; Sprague J; Barron A; Engelmann F; Yen B; Powers MF; Jones JM; Robinson BA; Orzechowska BU; Manoharan M; Legasse A; Planer S; Wilk J; Axthelm MK; Wong SW J Virol; 2011 Sep; 85(18):9527-42. PubMed ID: 21752919 [TBL] [Abstract][Full Text] [Related]